The Art of Gene Therapy- July 28-29, 2020
Join, The Art of Gene Therapy, a Virtual Summit- July 28-29, 2020
What is the future of gene therapy? How can we prepare for the future while still tackling the challenges of today?
Join the interactive dialog at The Art of Gene Therapy digital summit. This is a live two-day event drawing on the collective experience of industry leading gene therapy companies and regulatory agencies such as the FDA, Orchard Therapeutics, bluebird bio, REGENXBIO and many more.
The sessions will shine a light on gene therapy future technologies, technical challenges, lessons learned from scale up to commercialization and what is on the horizon for regulatory guidelines.
Take a look below at the exclusive line up we have across the two days:
Day 1, July 28:
- Introduction/Opening Remarks
- Yesterday’s Learnings: Trial and errors from scale up to commercialization
- Tomorrow’s View: What’s next for analytical development?
- Regulatory Horizons: 2020 vision on FDA guidelines
Day 2, July 29:
- The Next Decade of Gene Therapy: Q&A panel discussion
- Better Tomorrow: Industrializing AAV Production
- Futuristic outlook on Gene Therapy
- A-Gene: Applying Quality By Design Principles To The Development And Manufacture Of Gene Therapies
Register today and be at the forefront of the future of gene therapy.
- Congratulations Elevian! - November 23, 2021
- 2021 North America Biotech Start-up Symposium – NOW OPEN - October 20, 2021
- WEBINAR: Leveraging Next Generation Raman PAT Platform for Real-Time Bioprocess Monitoring - October 20, 2021
